ALEXA SHIPP: Open Payments
NPI 1659868933 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 48 payments from 11 companies in 2025. Trend: 2023 $806 · 2024 $890 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $195 |
| Novartis Pharmaceuticals Corporation | 7 | $121 |
| Actelion Pharmaceuticals US, Inc. | 5 | $110 |
| PFIZER INC. | 5 | $86 |
| Novo Nordisk Inc | 5 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| BridgeBio Pharma, Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Medtronic, Inc. | 1 | $20 |
Products named: VERQUVO, LEQVIO, Wegovy, UPTRAVI, JARDIANCE, VYNDAQEL, ELIQUIS, Attruby.
Industry payments across AR — which companies pay providers there.
